Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography

Aims Since the intravascular ultrasound (IVUS) cannot detect neointimal layers in the majority of sirolimus-eluting stents (SES) at the chronic phase, it is still controversial to what extent SES remain uncovered. However, optical coherence tomography (OCT) with excellent resolution may be able to d...

Full description

Saved in:
Bibliographic Details
Published inEuropean Heart Journal Vol. 28; no. 8; pp. 961 - 967
Main Authors Matsumoto, Daisuke, Shite, Junya, Shinke, Toshiro, Otake, Hiromasa, Tanino, Yusuke, Ogasawara, Daisuke, Sawada, Takahiro, Paredes, Oscar Luis, Hirata, Ken-ichi, Yokoyama, Mitsuhiro
Format Journal Article
LanguageEnglish
Published England Oxford University Press 01.04.2007
Oxford Publishing Limited (England)
Subjects
Online AccessGet full text
ISSN0195-668X
1522-9645
DOI10.1093/eurheartj/ehl413

Cover

Abstract Aims Since the intravascular ultrasound (IVUS) cannot detect neointimal layers in the majority of sirolimus-eluting stents (SES) at the chronic phase, it is still controversial to what extent SES remain uncovered. However, optical coherence tomography (OCT) with excellent resolution may be able to detect thinner neointima. Methods and results A total of 34 patients (57 SES) underwent OCT and IVUS evaluations at 6-month follow-up. The thickness of neointima on each SES strut cross-section and strut apposition to the vessel wall was evaluated. By OCT evaluation, the median (25th, 75th percentiles) neointima thickness was 52.5 µm (28.0 µm, 147.6 µm) and the prevalence of struts covered by thin neointima undetectable by IVUS was 64%. The average rate of neointima-covered struts in an individual SES was 89%. Nine SES (16%) showed full coverage by neointima, whereas the remaining stents had partially uncovered strut lesions. Among the 6840 struts visualized by OCT in all of the SES, 79 struts showed malapposition without neointimal coverage, and were frequently observed in the areas of SES overlap. Conclusion At 6 months, most of the SES were covered with thin neointima, but few showed full coverage.
AbstractList Aims Since the intravascular ultrasound (IVUS) cannot detect neointimal layers in the majority of sirolimus-eluting stents (SES) at the chronic phase, it is still controversial to what extent SES remain uncovered. However, optical coherence tomography (OCT) with excellent resolution may be able to detect thinner neointima. Methods and results A total of 34 patients (57 SES) underwent OCT and IVUS evaluations at 6-month follow-up. The thickness of neointima on each SES strut cross-section and strut apposition to the vessel wall was evaluated. By OCT evaluation, the median (25th, 75th percentiles) neointima thickness was 52.5 µm (28.0 µm, 147.6 µm) and the prevalence of struts covered by thin neointima undetectable by IVUS was 64%. The average rate of neointima-covered struts in an individual SES was 89%. Nine SES (16%) showed full coverage by neointima, whereas the remaining stents had partially uncovered strut lesions. Among the 6840 struts visualized by OCT in all of the SES, 79 struts showed malapposition without neointimal coverage, and were frequently observed in the areas of SES overlap. Conclusion At 6 months, most of the SES were covered with thin neointima, but few showed full coverage.
Since the intravascular ultrasound (IVUS) cannot detect neointimal layers in the majority of sirolimus-eluting stents (SES) at the chronic phase, it is still controversial to what extent SES remain uncovered. However, optical coherence tomography (OCT) with excellent resolution may be able to detect thinner neointima.AIMSSince the intravascular ultrasound (IVUS) cannot detect neointimal layers in the majority of sirolimus-eluting stents (SES) at the chronic phase, it is still controversial to what extent SES remain uncovered. However, optical coherence tomography (OCT) with excellent resolution may be able to detect thinner neointima.A total of 34 patients (57 SES) underwent OCT and IVUS evaluations at 6-month follow-up. The thickness of neointima on each SES strut cross-section and strut apposition to the vessel wall was evaluated. By OCT evaluation, the median (25th, 75th percentiles) neointima thickness was 52.5 microm (28.0 microm, 147.6 microm) and the prevalence of struts covered by thin neointima undetectable by IVUS was 64%. The average rate of neointima-covered struts in an individual SES was 89%. Nine SES (16%) showed full coverage by neointima, whereas the remaining stents had partially uncovered strut lesions. Among the 6840 struts visualized by OCT in all of the SES, 79 struts showed malapposition without neointimal coverage, and were frequently observed in the areas of SES overlap.METHODS AND RESULTSA total of 34 patients (57 SES) underwent OCT and IVUS evaluations at 6-month follow-up. The thickness of neointima on each SES strut cross-section and strut apposition to the vessel wall was evaluated. By OCT evaluation, the median (25th, 75th percentiles) neointima thickness was 52.5 microm (28.0 microm, 147.6 microm) and the prevalence of struts covered by thin neointima undetectable by IVUS was 64%. The average rate of neointima-covered struts in an individual SES was 89%. Nine SES (16%) showed full coverage by neointima, whereas the remaining stents had partially uncovered strut lesions. Among the 6840 struts visualized by OCT in all of the SES, 79 struts showed malapposition without neointimal coverage, and were frequently observed in the areas of SES overlap.At 6 months, most of the SES were covered with thin neointima, but few showed full coverage.CONCLUSIONAt 6 months, most of the SES were covered with thin neointima, but few showed full coverage.
Since the intravascular ultrasound (IVUS) cannot detect neointimal layers in the majority of sirolimus-eluting stents (SES) at the chronic phase, it is still controversial to what extent SES remain uncovered. However, optical coherence tomography (OCT) with excellent resolution may be able to detect thinner neointima. A total of 34 patients (57 SES) underwent OCT and IVUS evaluations at 6-month follow-up. The thickness of neointima on each SES strut cross-section and strut apposition to the vessel wall was evaluated. By OCT evaluation, the median (25th, 75th percentiles) neointima thickness was 52.5 microm (28.0 microm, 147.6 microm) and the prevalence of struts covered by thin neointima undetectable by IVUS was 64%. The average rate of neointima-covered struts in an individual SES was 89%. Nine SES (16%) showed full coverage by neointima, whereas the remaining stents had partially uncovered strut lesions. Among the 6840 struts visualized by OCT in all of the SES, 79 struts showed malapposition without neointimal coverage, and were frequently observed in the areas of SES overlap. At 6 months, most of the SES were covered with thin neointima, but few showed full coverage.
Aims Since the intravascular ultrasound (IVUS) cannot detect neointimal layers in the majority of sirolimus-eluting stents (SES) at the chronic phase, it is still controversial to what extent SES remain uncovered. However, optical coherence tomography (OCT) with excellent resolution may be able to detect thinner neointima. Methods and results A total of 34 patients (57 SES) underwent OCT and IVUS evaluations at 6-month follow-up. The thickness of neointima on each SES strut cross-section and strut apposition to the vessel wall was evaluated. By OCT evaluation, the median (25th, 75th percentiles) neointima thickness was 52.5 µm (28.0 µm, 147.6 µm) and the prevalence of struts covered by thin neointima undetectable by IVUS was 64%. The average rate of neointima-covered struts in an individual SES was 89%. Nine SES (16%) showed full coverage by neointima, whereas the remaining stents had partially uncovered strut lesions. Among the 6840 struts visualized by OCT in all of the SES, 79 struts showed malapposition without neointimal coverage, and were frequently observed in the areas of SES overlap. Conclusion At 6 months, most of the SES were covered with thin neointima, but few showed full coverage.
Author Hirata Ken-ichi
Yokoyama Mitsuhiro
Otake Hiromasa
Sawada Takahiro
Tanino Yusuke
Oscar Luis Paredes
Matsumoto Daisuke
Shinke Toshiro
Ogasawara Daisuke
Shite Junya
Author_xml – sequence: 1
  givenname: Daisuke
  surname: Matsumoto
  fullname: Matsumoto, Daisuke
  organization: Kobe University Graduate School of Medicine
– sequence: 2
  givenname: Junya
  surname: Shite
  fullname: Shite, Junya
  email: shite@med.kobe-u.ac.jp
  organization: Kobe University Graduate School of Medicine
– sequence: 3
  givenname: Toshiro
  surname: Shinke
  fullname: Shinke, Toshiro
  organization: Kobe University Graduate School of Medicine
– sequence: 4
  givenname: Hiromasa
  surname: Otake
  fullname: Otake, Hiromasa
  organization: Kobe University Graduate School of Medicine
– sequence: 5
  givenname: Yusuke
  surname: Tanino
  fullname: Tanino, Yusuke
  organization: Kobe University Graduate School of Medicine
– sequence: 6
  givenname: Daisuke
  surname: Ogasawara
  fullname: Ogasawara, Daisuke
  organization: Kobe University Graduate School of Medicine
– sequence: 7
  givenname: Takahiro
  surname: Sawada
  fullname: Sawada, Takahiro
  organization: Kobe University Graduate School of Medicine
– sequence: 8
  givenname: Oscar Luis
  surname: Paredes
  fullname: Paredes, Oscar Luis
  organization: Kobe University Graduate School of Medicine
– sequence: 9
  givenname: Ken-ichi
  surname: Hirata
  fullname: Hirata, Ken-ichi
  organization: Kobe University Graduate School of Medicine
– sequence: 10
  givenname: Mitsuhiro
  surname: Yokoyama
  fullname: Yokoyama, Mitsuhiro
  organization: Kobe University Graduate School of Medicine
BackLink https://cir.nii.ac.jp/crid/1570009752590953216$$DView record in CiNii
https://www.ncbi.nlm.nih.gov/pubmed/17135281$$D View this record in MEDLINE/PubMed
BookMark eNqNks1v1DAQxS1URLeFOydkIcQFhfojduzeUMWXVMEFJG6R453seuXYwXaK9r_HJQWkHhCXmcvvzYzemzN0EmIAhJ5S8poSzS9gSXswqRwuYO9byh-gDRWMNVq24gRtCNWikVJ9O0VnOR8IIUpS-Qid0o5ywRTdoPgJogvFTcZjG28gmR3gOOLsUvRuWnIDfiku7HAuEErGpmDZTDGUPR6j9_FHs8yXGG6MX0yBLR6OOM7F2V_z9pAgWMAlTnGXzLw_PkYPR-MzPLnr5-jru7dfrj4015_ff7x6c91Y0dLScN4pY5VglgzcdkQKLQTvmLQKmFWEiK5TmgCVvBuMbreDGdqWgBDKbvmo-Dl6uc6dU_y-QC795LIF702AuOS-Iy1pNRMVfH4PPMQlhXpbz6gQtGWcVujZHbQME2z7OVXD0rH_7WMFyArYFHNOMP5FSH8bVf8nqn6NqkrkPYl1xRRXrU3G-X8JX63CuMz_s-bFSgfn6obbSkVXX0F3gglNtOCsuvgTEI222Q
CitedBy_id crossref_primary_10_1007_s10554_009_9508_4
crossref_primary_10_4244_EIJ_D_20_01162
crossref_primary_10_4244_EIJV5I1A14
crossref_primary_10_1007_s00392_010_0163_5
crossref_primary_10_1536_ihj_20_627
crossref_primary_10_1016_j_jacc_2014_01_019
crossref_primary_10_1177_1358863X08095153
crossref_primary_10_1016_j_jjcc_2014_07_003
crossref_primary_10_1016_j_zemedi_2009_11_002
crossref_primary_10_1161_CIRCULATIONAHA_107_762096
crossref_primary_10_4244_EIJY15M12_05
crossref_primary_10_1016_j_ijcard_2009_04_039
crossref_primary_10_1016_j_ijcard_2010_11_006
crossref_primary_10_1253_circj_CJ_13_1540
crossref_primary_10_1016_j_jcmg_2011_03_014
crossref_primary_10_4244_EIJV3I5A104
crossref_primary_10_1007_s00380_021_01889_w
crossref_primary_10_2217_ica_09_29
crossref_primary_10_1093_eurheartj_ehq458
crossref_primary_10_1186_1476_7120_9_2
crossref_primary_10_1016_j_jjcc_2013_10_020
crossref_primary_10_1177_1526602815610116
crossref_primary_10_1016_j_ijcard_2009_07_012
crossref_primary_10_1002_ccd_24327
crossref_primary_10_1093_eurheartj_ehp480
crossref_primary_10_1007_s10554_011_0007_z
crossref_primary_10_1016_j_amjcard_2009_01_378
crossref_primary_10_1016_j_jcmg_2009_09_018
crossref_primary_10_1016_j_carrev_2008_11_003
crossref_primary_10_1016_j_jcin_2008_01_004
crossref_primary_10_4244_EIJV7I4A80
crossref_primary_10_1007_s10554_012_0046_0
crossref_primary_10_1007_s10554_019_01636_3
crossref_primary_10_2217_ica_09_37
crossref_primary_10_1016_j_jcin_2009_12_015
crossref_primary_10_1253_circj_CJ_09_0859
crossref_primary_10_4244_EIJV5I5A89
crossref_primary_10_1016_j_jcin_2011_08_015
crossref_primary_10_1007_s00380_013_0376_4
crossref_primary_10_1093_ehjci_jev108
crossref_primary_10_1016_j_ijcard_2020_08_016
crossref_primary_10_1007_s00059_011_3464_1
crossref_primary_10_1016_j_jcmg_2008_03_012
crossref_primary_10_1007_s10554_011_9849_7
crossref_primary_10_1016_j_ijcard_2013_10_023
crossref_primary_10_1016_j_jcin_2009_03_003
crossref_primary_10_1016_j_jcmg_2012_01_024
crossref_primary_10_1016_j_jjcc_2008_05_003
crossref_primary_10_1253_jjcsc_15_2_327
crossref_primary_10_1016_j_amjcard_2015_02_042
crossref_primary_10_1253_circj_CJ_08_1166
crossref_primary_10_1016_j_jcin_2009_03_006
crossref_primary_10_1111_j_1755_5922_2010_00187_x
crossref_primary_10_1161_JAHA_119_011975
crossref_primary_10_1136_heartasia_2013_010328
crossref_primary_10_1586_erc_13_37
crossref_primary_10_1093_eurheartj_ehs095
crossref_primary_10_1016_S1885_5857_09_71847_X
crossref_primary_10_33678_cor_2009_221
crossref_primary_10_1253_circj_CJ_10_1237
crossref_primary_10_1161_JAHA_120_020243
crossref_primary_10_1002_ccd_26673
crossref_primary_10_1016_j_jacl_2021_11_012
crossref_primary_10_1016_j_jconrel_2016_07_023
crossref_primary_10_1016_j_ahj_2010_06_043
crossref_primary_10_4244_EIJV6I1A62
crossref_primary_10_1186_1745_6215_13_55
crossref_primary_10_1016_j_ihj_2016_12_022
crossref_primary_10_1016_j_ijcha_2019_100382
crossref_primary_10_1161_CIRCINTERVENTIONS_108_802926
crossref_primary_10_1016_j_carrev_2014_04_005
crossref_primary_10_2217_ica_10_41
crossref_primary_10_2459_JCM_0b013e32832ffad3
crossref_primary_10_1093_ehjci_jes299
crossref_primary_10_2459_JCM_0b013e3283536b2b
crossref_primary_10_4244_EIJV5I2A35
crossref_primary_10_1007_s12928_009_0006_3
crossref_primary_10_1016_j_jcin_2010_02_008
crossref_primary_10_3349_ymj_2018_59_5_624
crossref_primary_10_6009_jjrt_65_1041
crossref_primary_10_1016_j_jjcc_2018_04_005
crossref_primary_10_1253_circj_CJ_12_0190
crossref_primary_10_1016_j_jcin_2011_04_007
crossref_primary_10_1016_j_iccl_2015_02_009
crossref_primary_10_1016_j_ijcard_2021_12_008
crossref_primary_10_4244_EIJV3I3A66
crossref_primary_10_4244_EIJV9I12A232
crossref_primary_10_1016_j_carrev_2015_12_001
crossref_primary_10_1016_j_jcmg_2011_03_020
crossref_primary_10_1002_ccd_23186
crossref_primary_10_1016_j_jjcc_2011_12_003
crossref_primary_10_1016_j_plabm_2021_e00202
crossref_primary_10_1007_s12410_014_9308_7
crossref_primary_10_1016_j_ahj_2023_05_004
crossref_primary_10_1007_s12928_018_0540_y
crossref_primary_10_3349_ymj_2013_54_5_1075
crossref_primary_10_2217_iim_11_24
crossref_primary_10_1016_j_jcin_2011_09_018
crossref_primary_10_1118_1_4943374
crossref_primary_10_1016_j_jcmg_2009_10_007
crossref_primary_10_47102_annals_acadmedsg_V39N3p221
crossref_primary_10_1007_s12350_009_9100_2
crossref_primary_10_1093_eurheartj_ehq168
crossref_primary_10_2169_naika_98_280
crossref_primary_10_4244_EIJV6I7A149
crossref_primary_10_2217_ica_11_34
crossref_primary_10_1016_j_ijcard_2020_01_024
crossref_primary_10_1016_S0300_8932_10_70201_3
crossref_primary_10_1016_j_ahj_2009_11_029
crossref_primary_10_1016_S1561_8811_12_80016_2
crossref_primary_10_1016_j_jcin_2015_07_017
crossref_primary_10_1161_JAHA_119_015579
crossref_primary_10_1016_j_amjcard_2008_02_091
crossref_primary_10_1186_s12933_016_0395_4
crossref_primary_10_3760_cma_j_issn_0366_6999_2010_05_014
crossref_primary_10_1016_j_ijcard_2008_05_069
crossref_primary_10_1007_s10554_018_1384_3
crossref_primary_10_2459_JCM_0b013e3283406428
crossref_primary_10_1016_j_jjcc_2016_12_011
crossref_primary_10_1161_CIRCINTERVENTIONS_115_003469
crossref_primary_10_1253_circj_CJ_09_0792
crossref_primary_10_1253_circj_CJ_08_1116
crossref_primary_10_1016_j_rbci_2015_02_001
crossref_primary_10_2459_JCM_0b013e3283403409
crossref_primary_10_4244_EIJV4I4A89
crossref_primary_10_1155_2009_816715
crossref_primary_10_1253_circj_CJ_11_1363
crossref_primary_10_1016_j_jcmg_2021_03_028
crossref_primary_10_1253_circj_CJ_11_1122
crossref_primary_10_4244_EIJY14M10_01
crossref_primary_10_1016_j_ejvs_2013_03_005
crossref_primary_10_1016_j_ijcard_2010_05_004
crossref_primary_10_4244_EIJV9I8A159
crossref_primary_10_1016_j_jcin_2009_10_031
crossref_primary_10_1016_j_jcin_2012_05_012
crossref_primary_10_1016_j_ijcard_2012_03_084
crossref_primary_10_1016_j_rbciev_2015_02_001
crossref_primary_10_1093_eurheartj_ehq066
crossref_primary_10_1007_s00380_018_1131_7
crossref_primary_10_1161_CIRCINTERVENTIONS_110_950154
crossref_primary_10_3760_cma_j_issn_0366_6999_20121485
crossref_primary_10_1177_0300985811400446
crossref_primary_10_1536_ihj_21_826
crossref_primary_10_4244_EIJV6I1A13
crossref_primary_10_1186_1757_1626_3_68
crossref_primary_10_1007_s10554_012_0031_7
crossref_primary_10_1586_14779072_2016_1112267
crossref_primary_10_1088_0031_9155_53_12_001
crossref_primary_10_1536_ihj_20_458
crossref_primary_10_1016_j_ijcard_2011_05_076
crossref_primary_10_1117_1_3290810
crossref_primary_10_1536_ihj_18_531
crossref_primary_10_1016_j_jjcc_2010_05_005
crossref_primary_10_1161_CIRCINTERVENTIONS_108_770008
crossref_primary_10_1097_MAJ_0b013e31816c7bdf
crossref_primary_10_1016_j_jjcc_2015_07_014
crossref_primary_10_1093_ehjci_jes025
crossref_primary_10_4103_heartindia_heartindia_38_19
crossref_primary_10_1253_circj_CJ_10_0525
crossref_primary_10_1016_j_jcin_2010_08_006
crossref_primary_10_1016_j_amjcard_2009_03_047
crossref_primary_10_1016_j_ihj_2012_11_008
crossref_primary_10_1016_j_jjcc_2015_12_011
crossref_primary_10_2217_fca_11_59
crossref_primary_10_1002_ccd_21482
crossref_primary_10_1016_j_ijcard_2012_02_013
crossref_primary_10_1253_circj_CJ_09_0690
crossref_primary_10_1253_circj_CJ_13_1474
crossref_primary_10_1371_journal_pone_0240860
crossref_primary_10_1016_j_jcin_2007_10_004
crossref_primary_10_1007_s12928_017_0507_4
crossref_primary_10_1007_s10554_010_9729_6
crossref_primary_10_1016_S0300_8932_09_71046_2
crossref_primary_10_1016_j_amjcard_2009_11_018
crossref_primary_10_1016_j_ijcard_2014_11_068
crossref_primary_10_1016_j_amjcard_2016_03_038
crossref_primary_10_3904_kjim_2012_27_1_1
crossref_primary_10_4244_EIJ_D_19_00206
crossref_primary_10_1016_S0300_8932_10_70207_4
crossref_primary_10_1007_s11239_015_1207_5
crossref_primary_10_1016_j_jcin_2008_12_006
crossref_primary_10_1016_S1885_5857_10_70183_3
crossref_primary_10_1161_CIRCINTERVENTIONS_110_957118
crossref_primary_10_1016_j_jcin_2009_01_012
crossref_primary_10_1586_17434440_6_2_157
crossref_primary_10_2174_1874306401307010026
crossref_primary_10_1016_j_jcin_2009_01_010
crossref_primary_10_1016_j_jacl_2018_10_007
crossref_primary_10_1042_CS20180879
crossref_primary_10_1159_000357612
crossref_primary_10_1007_s10554_011_9905_3
crossref_primary_10_1093_eurheartj_ehv768
crossref_primary_10_1007_s12410_012_9138_4
crossref_primary_10_15791_angioscopy_re_17_0017
crossref_primary_10_1016_j_jbiomech_2017_09_016
crossref_primary_10_1007_s12410_009_0032_7
crossref_primary_10_1016_j_jcin_2010_04_005
crossref_primary_10_1253_circj_CJ_08_0746
crossref_primary_10_1007_s10554_011_9796_3
crossref_primary_10_1007_BF02938368
crossref_primary_10_1111_j_1540_8183_2009_00485_x
crossref_primary_10_1016_j_jacc_2009_11_052
crossref_primary_10_1253_circj_CJ_09_0113
crossref_primary_10_1016_j_jacl_2023_01_004
crossref_primary_10_2217_ica_12_71
crossref_primary_10_1007_s12928_022_00877_9
crossref_primary_10_1007_s12350_009_9060_6
crossref_primary_10_1253_circj_CJ_13_0374
crossref_primary_10_1007_s11886_020_01299_w
crossref_primary_10_1007_s00380_015_0728_3
crossref_primary_10_1016_j_jcin_2009_08_003
crossref_primary_10_3349_ymj_2011_52_6_1028
crossref_primary_10_1016_j_jbiomech_2013_10_048
crossref_primary_10_1007_s12928_011_0051_6
crossref_primary_10_1586_17434440_5_6_691
crossref_primary_10_1016_j_atherosclerosis_2007_12_055
crossref_primary_10_1586_17434440_6_1_33
crossref_primary_10_1002_ccd_25610
crossref_primary_10_1016_j_jcmg_2009_01_011
crossref_primary_10_1155_2012_956962
crossref_primary_10_1161_CIRCINTERVENTIONS_113_001146
crossref_primary_10_1253_circj_CJ_09_0377
crossref_primary_10_1016_j_jcin_2009_10_006
crossref_primary_10_2217_ica_13_62
crossref_primary_10_3892_mmr_2013_1313
crossref_primary_10_1016_j_cjca_2015_06_029
crossref_primary_10_1016_j_jcin_2012_09_017
crossref_primary_10_1253_circj_CJ_11_0961
crossref_primary_10_1016_j_ijcard_2008_11_204
crossref_primary_10_1093_ehjci_jet088
crossref_primary_10_1109_TMI_2009_2037755
crossref_primary_10_1016_j_acvd_2009_05_010
crossref_primary_10_1016_j_jcin_2011_03_020
crossref_primary_10_1253_circj_CJ_11_0845
crossref_primary_10_1161_CIRCINTERVENTIONS_109_868398
crossref_primary_10_1002_ccd_21606
crossref_primary_10_1016_j_jjcc_2015_06_011
crossref_primary_10_1111_j_1540_8183_2009_00458_x
crossref_primary_10_4244_EIJ_D_15_00399
crossref_primary_10_1016_j_jcin_2007_11_001
crossref_primary_10_1115_1_4043866
crossref_primary_10_1016_j_ijcard_2012_10_043
crossref_primary_10_1007_s10554_013_0282_y
crossref_primary_10_2217_nnm_16_3
crossref_primary_10_4244_EIJV7I3A60
crossref_primary_10_1007_s12181_007_0012_6
crossref_primary_10_1016_j_ijcard_2010_12_072
crossref_primary_10_1016_S1885_5857_10_70189_4
crossref_primary_10_1016_j_acvd_2010_12_004
crossref_primary_10_1016_j_amjcard_2008_08_057
crossref_primary_10_1016_j_cjca_2015_02_036
crossref_primary_10_1111_jon_12223
crossref_primary_10_1002_rcs_2033
crossref_primary_10_1253_circj_CJ_14_0315
crossref_primary_10_1093_ehjci_jeu188
crossref_primary_10_2217_ica_09_13
crossref_primary_10_1002_ccd_26969
crossref_primary_10_4244_EIJV11I5A109
crossref_primary_10_4244_EIJV7SKA16
crossref_primary_10_1016_j_jacc_2007_12_059
crossref_primary_10_1002_ccd_22125
crossref_primary_10_1002_ccd_23215
ContentType Journal Article
Copyright The European Society of Cardiology 2006. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org 2007
Copyright Oxford University Press(England) Apr 2007
Copyright_xml – notice: The European Society of Cardiology 2006. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org 2007
– notice: Copyright Oxford University Press(England) Apr 2007
DBID RYH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QP
K9.
7X8
DOI 10.1093/eurheartj/ehl413
DatabaseName CiNii Complete
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Calcium & Calcified Tissue Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Calcium & Calcified Tissue Abstracts
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE
ProQuest Health & Medical Complete (Alumni)
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate D. Matsumoto et al.SES follow-up with OCT
EISSN 1522-9645
EndPage 967
ExternalDocumentID 1261029451
17135281
10_1093_eurheartj_ehl413
10.1093/eurheartj/ehl413
120001075377
Genre Journal Article
GroupedDBID ---
-E4
.2P
.I3
.XZ
.ZR
08P
0R~
18M
1TH
29G
2WC
4.4
482
48X
53G
5GY
5RE
5VS
5WA
5WD
70D
AABZA
AACZT
AAFWJ
AAJKP
AAJQQ
AAMVS
AAOGV
AAPNW
AAPQZ
AAPXW
AARHZ
AAUAY
AAUQX
AAVAP
ABDFA
ABEJV
ABEUO
ABGNP
ABIXL
ABJNI
ABKDP
ABNGD
ABNHQ
ABNKS
ABOCM
ABPQP
ABPTD
ABQLI
ABQNK
ABVGC
ABWST
ABXVV
ABZBJ
ACGFO
ACGFS
ACPRK
ACUFI
ACUKT
ACUTJ
ACUTO
ACYHN
ADBBV
ADEYI
ADEZT
ADGHP
ADGZP
ADHKW
ADHZD
ADIPN
ADNBA
ADOCK
ADQBN
ADRTK
ADVEK
ADYVW
ADZXQ
AEGPL
AEGXH
AEJOX
AEKSI
AEMDU
AEMQT
AENEX
AENZO
AEPUE
AETBJ
AEWNT
AFFNX
AFFZL
AFIYH
AFOFC
AFXAL
AFYAG
AGINJ
AGKEF
AGORE
AGQPQ
AGQXC
AGSYK
AGUTN
AHMBA
AHMMS
AHXPO
AIAGR
AIJHB
AJBYB
AJEEA
AJNCP
ALMA_UNASSIGNED_HOLDINGS
ALUQC
ALXQX
APIBT
APWMN
ASPBG
ATGXG
AVWKF
AXUDD
AZFZN
BAWUL
BAYMD
BCGUY
BCRHZ
BEYMZ
BHONS
BTRTY
BVRKM
C1A
C45
CAG
CDBKE
COF
CS3
CZ4
DAKXR
DIK
DILTD
D~K
E3Z
EBS
EE~
EJD
EMOBN
ENERS
F5P
F9B
FECEO
FEDTE
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
GX1
H13
H5~
HAR
HVGLF
HW0
HZ~
IOX
J21
JXSIZ
KAQDR
KBUDW
KOP
KQ8
KSI
KSN
L7B
M-Z
M41
MHKGH
ML0
N9A
NGC
NOMLY
NOYVH
NTWIH
NU-
NVLIB
O0~
O9-
OAUYM
OAWHX
OB3
OCZFY
ODMLO
OGROG
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
P2P
PAFKI
PB-
PEELM
PQQKQ
Q1.
Q5Y
R44
RD5
ROL
ROX
ROZ
RUSNO
RW1
RXO
RYH
SEL
TCURE
TEORI
TJX
W8F
WOQ
X7H
YAYTL
YKOAZ
YXANX
ZKX
~91
--K
.GJ
1B1
6.Y
AAPGJ
AASNB
AAWDT
ABQTQ
ABSAR
ABSMQ
ACFRR
ACMRT
ACPQN
ACZBC
ADJQC
ADRIX
AEKPW
AFSHK
AFXEN
AGKRT
AGMDO
AI.
APJGH
AQDSO
AQKUS
ATTQO
AVNTJ
BZKNY
EIHJH
IHE
KC5
M49
MBLQV
N4W
NQ-
O~Y
QBD
RIG
RNI
RPZ
RZF
TMA
UHS
VH1
ZGI
AAYXX
CITATION
AEHUL
AFFQV
CGR
CUY
CVF
ECM
EIF
NPM
7QP
K9.
7X8
ID FETCH-LOGICAL-c541t-3378ac852c0b3c70659553726c8e2c800577890e1637ba94dbab440e558cd3f83
ISSN 0195-668X
IngestDate Fri Jul 11 10:03:48 EDT 2025
Sun Jun 29 16:19:45 EDT 2025
Wed Feb 19 01:47:14 EST 2025
Thu Apr 24 23:03:36 EDT 2025
Tue Jul 01 01:09:25 EDT 2025
Wed Aug 28 03:24:38 EDT 2024
Fri Jun 27 00:13:35 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords Neointima
Malapposition
Optical coherence tomography
Sirolimus-eluting stents
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c541t-3378ac852c0b3c70659553726c8e2c800577890e1637ba94dbab440e558cd3f83
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://hdl.handle.net/20.500.14094/90000682
PMID 17135281
PQID 215514231
PQPubID 29905
PageCount 7
ParticipantIDs proquest_miscellaneous_70404925
proquest_journals_215514231
pubmed_primary_17135281
crossref_primary_10_1093_eurheartj_ehl413
crossref_citationtrail_10_1093_eurheartj_ehl413
oup_primary_10_1093_eurheartj_ehl413
nii_cinii_1570009752590953216
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2007-04-01
PublicationDateYYYYMMDD 2007-04-01
PublicationDate_xml – month: 04
  year: 2007
  text: 2007-04-01
  day: 01
PublicationDecade 2000
PublicationPlace England
PublicationPlace_xml – name: England
– name: Oxford
PublicationTitle European Heart Journal
PublicationTitleAlternate Eur Heart J
PublicationYear 2007
Publisher Oxford University Press
Oxford Publishing Limited (England)
Publisher_xml – name: Oxford University Press
– name: Oxford Publishing Limited (England)
References 17347174 - Eur Heart J. 2007 Apr;28(8):918-9
References_xml – reference: 17347174 - Eur Heart J. 2007 Apr;28(8):918-9
SSID ssj0008616
Score 2.3953621
Snippet Aims Since the intravascular ultrasound (IVUS) cannot detect neointimal layers in the majority of sirolimus-eluting stents (SES) at the chronic phase, it is...
Since the intravascular ultrasound (IVUS) cannot detect neointimal layers in the majority of sirolimus-eluting stents (SES) at the chronic phase, it is still...
Aims Since the intravascular ultrasound (IVUS) cannot detect neointimal layers in the majority of sirolimus-eluting stents (SES) at the chronic phase, it is...
SourceID proquest
pubmed
crossref
oup
nii
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 961
SubjectTerms Aged
Aspirin - therapeutic use
Catheterization
Cell Proliferation
Coronary Restenosis - drug therapy
Coronary Restenosis - pathology
Coronary Thrombosis - pathology
Drug Therapy, Combination
Female
Follow-Up Studies
Humans
Immunosuppressive Agents - administration & dosage
Male
Sirolimus - administration & dosage
Stents
Ticlopidine - therapeutic use
Tomography, Optical Coherence
Tunica Intima - pathology
Title Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography
URI https://cir.nii.ac.jp/crid/1570009752590953216
https://www.ncbi.nlm.nih.gov/pubmed/17135281
https://www.proquest.com/docview/215514231
https://www.proquest.com/docview/70404925
Volume 28
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Pb9MwFLa6ISEuiN-UMfBhF1SFNY4dO9wQ2qimrRxopd6CkyZqxppUiyM0_nqe7dRNVwSDixU5je36fXmxn9_7HkJHGSfDuQTtN0wI9SinwpO5n3ucEcGY5PCZ0MHJF-NwNKVnMzbr9b51vJYalbxPf_42ruR_pAp1IFcdJfsPknWNQgVcg3yhBAlDeScZj7OqKFWxNBwfMHppLQB1oVPxLJvay3TvxmBgAtmkGoQejE4tBjnIv_rhNSuTmsdSftvFaLVSLWvIoqWgVdWyS2x9246vc2KrQXfAxsKtYCYqk6QJoFXUzXcHoa_rpHxnTXkjO7Wl9RSaVNpkXjn7r5K2fgSVS1nLLUsF7zi4tMbLiHlhaFIJO-1LRAdloqNKI0vSvqPiLf1V1lybf3eprxdX1Aa0bvNpj7_Ep9Pz83hyMpvsoXuEc3OQ_3m2cQISoUmO60bWHmRDH8euh2Pb_tbCZa8silshkTs7E7NCmTxCD9utBf5ocfIY9bLyCbp_0TpPPEXVBi54DRdc5XgHLtjCBUuFW7hgB5cP2IEFJze4BQt2YMEbsDxD09OTyaeR1-bb8FJGfeUFARcyFYykwyRI9fl3xFjASZiKjKRCxy3rsOkMlvA8kRGdJzKhdJgxJtJ5kIvgOdovqzJ7ifDcZ0JSaI7QgPKAJjnsi_NhznPJM5GnfXS8nsw4bcnodU6Uq9g6RQSxm_7YTn8fvXNPrCwRyx9-ewjygYZ16esMDsMIlA-LNLki8cM-OgLJ3aGZg7Vo4_YlqmNi9hiwK-qjt-4uqGR9zibLrGrqmMOHUXN-9tELi4dNTzohJhH-q78-e4AebF6h12hfXTfZISx_VfLGIPgX9W-3vg
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Neointimal+coverage+of+sirolimus-eluting+stents+at+6-month+follow-up%3A+evaluated+by+optical+coherence+tomography&rft.jtitle=European+heart+journal&rft.au=Matsumoto%2C+Daisuke&rft.au=Shite%2C+Junya&rft.au=Shinke%2C+Toshiro&rft.au=Otake%2C+Hiromasa&rft.date=2007-04-01&rft.issn=0195-668X&rft.volume=28&rft.issue=8&rft.spage=961&rft_id=info:doi/10.1093%2Feurheartj%2Fehl413&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0195-668X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0195-668X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0195-668X&client=summon